HomeTagsVabysmo

Vabysmo

Biotechnology

FDA Approves Genentech’s Vabysmo Prefilled Syringe (PFS) for Three Leading Causes of Vision Loss

News Desk - July 8, 2024

Genentech, a member of the Roche Group announced the U.S. Food and Drug Administration (FDA) has approved the Vabysmo (faricimab-svoa) 6.0 mg single-dose prefilled...

Healthcare

FDA approves Roche’s Vabysmo prefilled syringe (PFS) for three leading causes of vision loss

News Desk - July 5, 2024

Roche announced the United States Food and Drug Administration (US FDA) has approved the Vabysmo 6.0 mg single-dose prefilled syringe (PFS) for use in...